Example: Heart Attack

Clinical Trials on Neoplasms, Squamous Cell

Total 2458 results

NCT01075841

Withdrawn

A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck

Conditions: Neoplasms, Squamous Cell
NCT00229723

Completed

IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma

Conditions: Neoplasms, Squamous Cell
NCT01709448

Unknown status

Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV

Conditions: Neoplasms, Squamous Cell; Papillomavirus Infections
NCT01741727

Completed

A Study of ABT-414 in Subjects With Solid Tumors

Conditions: Squamous Cell Tumors
NCT03183115

Recruiting

RFA to Prevent Metachronous Squamous Neoplasia Recurrence After Complete Endoscopic Submucosal Dissection

Conditions: Esophageal Squamous Cell Neoplasm
NCT03937791

Terminated

Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Conditions: Squamous Lntraepithelial Lesions of Vulva; Neoplasms, Squamous Cell; Vulvar HSIL
NCT02268747

Unknown status

Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer

Conditions: Skin Squamous Cell Cancer
NCT01075828

Completed

Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea

Conditions: Head and Neck Cancer
NCT02784288

Active, not recruiting

Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer

Conditions: Oropharyngeal Squamous Cell Cancer
NCT03138070

Recruiting

A Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) By Preoperative Treatment With BYL719

Conditions: Head and Neck Squamous Cell Cancer
NCT02485548

Unknown status

Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer

Conditions: Head and Neck Squamous Cell Cancer
NCT02282371

Active, not recruiting

Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)

Conditions: Head and Neck Squamous Cell Cancer
NCT01914900

Completed

Preoperative TPF Chemotherapy in a Population of Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer

Conditions: Locally Advanced Resectable Oral Cavity Squamous Cell Cancer
NCT02083692

Completed

Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling

Conditions: Head and Neck Squamous Cell Cancer
NCT00530283

Completed

PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy

Conditions: Squamous Cell Cancer
NCT03667482

Recruiting

Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Conditions: Head and Neck Squamous Cell Cancer; Recurrent Head and Neck Squamous Cell Cancer; Metastatic Head and Neck Squamous Cell Cancer
NCT01326923

Terminated

Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer

Conditions: Head and Neck Squamous Cell Cancer
NCT01721525

Completed

Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC)

Conditions: Head and Neck Cancer; Squamous Cell Cancer
NCT01016769

Completed

Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)

Conditions: Squamous Cell Cancer; Head and Neck Cancer
NCT00661427

Completed

Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Conditions: Head and Neck; Squamous Cell Cancer
NCT00815295

Completed

Study of Sorafenib/Cetuximab in Head and Neck Cancer

Conditions: Squamous Cell Cancer
NCT00705016

Completed

Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Conditions: Squamous Cell Cancer
NCT04671940

Recruiting

Exploratory Study of Clonal Evolution in Cancer for Patients Undergoing Transoral Robotic Surgery for Radiation Exposed Residual/reCurrent Tumours of the Upper Aerodigestive Tract

Conditions: Head & Neck Squamous Cell Cancer (HNSCC)
NCT00768664

Completed

Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer

Conditions: Head and Neck Neoplasms
NCT02842125

Terminated

Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer

Conditions: Metastatic Solid Tumor Cancer; Recurrent Head and Neck Cancer